H. Lin, A. S. Ho, D. Haley-vicente, J. Zhang, J. Bernal-fussell et al., Cloning and Characterization of IL-1HY2, a Novel Interleukin-1 Family Member, Journal of Biological Chemistry, vol.161, issue.23, pp.20597-20602, 2001.
DOI : 10.1074/jbc.270.23.13757

J. T. Bensen, P. A. Dawson, J. C. Mychaleckyj, and D. W. Bowden, Identification of a Novel Human Cytokine Gene in the Interleukin Gene Cluster on Chromosome 2q12-14, Journal of Interferon & Cytokine Research, vol.21, issue.11, pp.899-904, 2001.
DOI : 10.1089/107999001753289505

S. Carta, R. Lavieri, and A. Rubartelli, Different Members of the IL-1 Family Come Out in Different Ways: DAMPs vs. Cytokines?, Frontiers in Immunology, vol.4, issue.123, 2013.
DOI : 10.3389/fimmu.2013.00123

S. Takenaka, S. Kaieda, T. Kawayama, M. Matsuoka, Y. Kaku et al., IL-38: A new factor in rheumatoid arthritis, Biochemistry and Biophysics Reports, vol.4, pp.386-391, 2015.
DOI : 10.1016/j.bbrep.2015.10.015

J. Palomo, D. Dietrich, P. Martin, G. Palmer, and C. Gabay, The interleukin (IL)-1 cytokine family ??? Balance between agonists and antagonists in inflammatory diseases, Cytokine, vol.76, issue.1, pp.25-37, 2015.
DOI : 10.1016/j.cyto.2015.06.017

M. Y. Jung, S. W. Kang, S. K. Kim, H. Kim, D. H. Yun et al., The interleukin-1 family gene polymorphisms in Korean patients with rheumatoid arthritis, Scandinavian Journal of Rheumatology, vol.115, issue.3, pp.190-196, 2010.
DOI : 10.3901/JME.2002.03.046

D. Monnet, A. Kadi, B. Izac, N. Lebrun, F. Letourneur et al., Association between the IL-1 family gene cluster and spondyloarthritis, Annals of the Rheumatic Diseases, vol.71, issue.6, pp.885-890, 2011.
DOI : 10.1136/annrheumdis-2011-200439

Z. S. Guo, C. Li, Z. M. Lin, J. X. Huang, Q. J. Wei et al., Association of IL-1 gene complex members with ankylosing spondylitis in Chinese Han population, International Journal of Immunogenetics, vol.41, issue.1, pp.33-37, 2010.
DOI : 10.1111/j.1744-313X.2009.00889.x

C. Chou, A. E. Timms, J. C. Wei, W. C. Tsai, B. P. Wordsworth et al., Replication of association of IL1 gene complex members with ankylosing spondylitis in Taiwanese Chinese, Annals of the Rheumatic Diseases, vol.65, issue.8, pp.1106-1109, 2006.
DOI : 10.1136/ard.2005.046847

W. Lea and Y. H. Lee, The associations between interleukin-1 polymorphisms and susceptibility to ankylosing spondylitis: A meta-analysis, Joint Bone Spine, vol.79, issue.4, pp.370-374, 2012.
DOI : 10.1016/j.jbspin.2011.06.010

P. Rahman, S. Sun, L. Peddle, T. Snelgrove, W. Melay et al., Association between the interleukin-1 family gene cluster and psoriatic arthritis, Arthritis & Rheumatism, vol.68, issue.7, pp.2321-2325, 2006.
DOI : 10.1002/art.21928

C. J. Stock, E. M. Ogilvie, J. M. Samuel, M. Fife, C. M. Lewis et al., Comprehensive association study of genetic variants in the IL-1 gene family in systemic juvenile idiopathic arthritis, Genes & Immunity, vol.447, issue.4, pp.349-357, 2008.
DOI : 10.1086/519795

A. Dehghan, J. Dupuis, M. Barbalic, J. C. Bis, G. Eiriksdottir et al., Meta-Analysis of Genome-Wide Association Studies in >80 000 Subjects Identifies Multiple Loci for C-Reactive Protein Levels, Circulation, vol.123, issue.7, pp.731-738, 2011.
DOI : 10.1161/CIRCULATIONAHA.110.948570

M. E. Soto-lópez, R. Gamboa-Ávila, E. Hernández, C. Huesca-gómez, V. Castrejón-téllez et al., The Interleukin-1 Gene Cluster Polymorphisms Are Associated with Takayasu's Arteritis in Mexican Patients, Journal of Interferon & Cytokine Research, vol.33, issue.7, pp.369-375, 2013.
DOI : 10.1089/jir.2012.0126

C. Herder, M. Nuotio, S. Shah, S. Blankenberg, E. J. Brunner et al., Genetic Determinants of Circulating Interleukin-1 Receptor Antagonist Levels and Their Association With Glycemic Traits, Diabetes, vol.63, issue.12, pp.4343-4359, 2014.
DOI : 10.2337/db14-0731

F. L. Van-de-veerdonk, A. K. Stoeckman, G. Wu, A. N. Boeckermann, T. Azam et al., IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist, Proceedings of the National Academy of Sciences, vol.270, issue.19, pp.3001-3005, 2012.
DOI : 10.1074/jbc.270.19.11477

I. Rudloff, J. Godsell, C. A. Nold-petry, J. Harris, A. Hoi et al., Brief Report: Interleukin-38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus, Arthritis & Rheumatology, vol.71, issue.12, pp.3219-3225, 2015.
DOI : 10.1016/j.humimm.2010.06.004

J. Mora, A. Schlemmer, I. Wittig, F. Richter, M. Putyrski et al., Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses, Journal of Molecular Cell Biology, vol.4, issue.5, pp.426-438, 2016.
DOI : 10.1016/j.cell.2010.02.015

M. Boutet, A. Najm, G. Bart, R. Brion, S. Touchais et al., IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro, Annals of the Rheumatic Diseases, vol.286, issue.7, pp.1304-1312, 2017.
DOI : 10.1136/annrheumdis-2016-210630

URL : https://hal.archives-ouvertes.fr/inserm-01671438

H. C. Jha, P. Srivastava, H. Vardhan, L. C. Singh, A. R. Bhengraj et al., Chlamydia pneumoniae heat shock protein 60 is associated with apoptotic signaling pathway in human atheromatous plaques of coronary artery disease patients, Journal of Cardiology, vol.58, issue.3, pp.216-225, 2011.
DOI : 10.1016/j.jjcc.2011.07.010

F. Ciccia, A. Accardo-palumbo, R. Alessandro, C. Alessandri, R. Priori et al., Interleukin-36?? axis is modulated in patients with primary Sj??gren's syndrome, Clinical & Experimental Immunology, vol.35, issue.2, pp.230-238, 2015.
DOI : 10.1016/j.immuni.2011.08.001

B. Zhao, W. Chen, R. Jiang, R. Zhang, Y. Wang et al., Expression profile of IL-1 family cytokines in aqueous humor and sera of patients with HLA-B27 associated anterior uveitis and idiopathic anterior uveitis, Experimental Eye Research, vol.138, pp.80-86, 2015.
DOI : 10.1016/j.exer.2015.06.018

Y. Zhong, K. Yu, X. Wang, X. Wang, Q. Ji et al., Elevated Plasma IL-38 Concentrations in Patients with Acute ST-Segment Elevation Myocardial Infarction and Their Dynamics after Reperfusion Treatment, Mediators of Inflammation, vol.68, issue.6, 2015.
DOI : 10.1161/01.CIR.96.3.778

M. Boutet, G. Bart, M. Penhoat, J. Amiaud, B. Brulin et al., , their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease, Clinical & Experimental Immunology, vol.1849, issue.2, pp.159-173, 2016.
DOI : 10.1016/j.bbagrm.2015.06.002

URL : http://onlinelibrary.wiley.com/doi/10.1111/cei.12761/pdf

X. Yuan, Y. Li, X. Pan, X. Peng, G. Song et al., IL-38 alleviates concanavalin A-induced liver injury in mice, International Immunopharmacology, vol.40, pp.452-457, 2016.
DOI : 10.1016/j.intimp.2016.09.023

H. Wang, Y. Jiang, X. Wang, M. Zhang, and P. Gao, Elevated serum interleukin-38 level at baseline predicts virological response in telbivudine-treated patients with chronic hepatitis B, World Journal of Gastroenterology, vol.22, issue.18, pp.4529-4537, 2016.
DOI : 10.1371/journal.ppat.1003208

M. Chu, I. M. Chu, E. C. Yung, C. W. Lam, T. F. Leung et al., Aberrant Expression of Novel Cytokine IL-38 and Regulatory T Lymphocytes in Childhood Asthma, Molecules, vol.21, issue.7, 2016.
DOI : 10.1016/j.jaci.2012.06.025

H. J. Kim, S. H. Kim, J. Park, M. Lee, D. S. Kim et al., Up-regulation of receptor antagonist interleukin-1 family members in psoriasis and their regulation by pro-inflammatory cytokines, Journal of Dermatological Science, vol.82, issue.3, pp.204-206, 2016.
DOI : 10.1016/j.jdermsci.2016.02.003

M. Wang, B. Wang, Z. Ma, X. Sun, Y. Tang et al., Detection of the novel IL-1 family cytokines by QAH-IL1F-1 assay in rheumatoid arthritis, Cell. Mol. Biol, pp.62-93, 2016.

J. Zhang, R. Zhao, J. Chen, J. Jin, Y. Yu et al., The effect of interleukin 38 on angiogenesis in a model of oxygen-induced retinopathy , Sci, 2017.

J. Li, L. Liu, W. Rui, X. Li, D. Xuan et al., New Interleukins in Psoriasis and Psoriatic Arthritis Patients: The Possible Roles of Interleukin-33 to Interleukin-38 in Disease Activities and Bone Erosions, Dermatology, vol.233, issue.1, pp.233-2017
DOI : 10.1159/000471798

M. Chu, L. S. Tam, J. Zhu, D. Jiao, D. H. Liu et al., In vivo anti-inflammatory activities of novel cytokine IL-38 in Murphy Roths Large (MRL)/lpr mice, Immunobiology, vol.222, issue.3, pp.483-493, 2017.
DOI : 10.1016/j.imbio.2016.10.012

M. Tominaga, M. Okamoto, T. Kawayama, M. Matsuoka, S. Kaieda et al., Overexpression of IL-38 protein in anticancer drug-induced lung injury and acute exacerbation of idiopathic pulmonary fibrosis, Respiratory Investigation, vol.55, issue.5, pp.293-299, 2017.
DOI : 10.1016/j.resinv.2017.06.001

K. Takada, T. Okamoto, M. Tominaga, K. Teraishi, T. Akamine et al., Clinical implications of the novel cytokine IL-38 expressed in lung adenocarcinoma: Possible association with PD-L1 expression, PLOS ONE, vol.14, issue.4, 2017.
DOI : 10.1371/journal.pone.0181598.s001

M. Sabater-lleal, J. Huang, D. Chasman, S. Naitza, A. Dehghan et al., Multiethnic Meta-Analysis of Genome-Wide Association Studies in >100 000 Subjects Identifies 23 Fibrinogen-Associated Loci but No Strong Evidence of a Causal Association Between Circulating Fibrinogen and Cardiovascular Disease, Circulation, vol.128, issue.12, pp.1310-1324, 2013.
DOI : 10.1161/CIRCULATIONAHA.113.002251

S. Hessam, M. Sand, T. Gambichler, M. Skrygan, I. Rüddel et al., IL-36 in hidradenitis suppurativa: Evidence for a distinctive pro-inflammatory role and a key factor in the development of an inflammatory loop, British Journal of Dermatology, 2017.
DOI : 10.1111/bjd.16019

Z. Yu, J. Liu, R. Zhang, X. Huang, T. Sun et al., IL-37 and 38 signalling in gestational diabetes, Journal of Reproductive Immunology, vol.124, pp.8-14, 2017.
DOI : 10.1016/j.jri.2017.09.011

I. S. Afonina, C. Müller, S. J. Martin, and R. Beyaert, Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme, Immunity, vol.42, issue.6, pp.991-1004, 2015.
DOI : 10.1016/j.immuni.2015.06.003

D. M. Clancy, C. M. Henry, G. P. Sullivan, and S. J. Martin, Neutrophil extracellular traps can serve as platforms for processing and activation of IL-1 family cytokines, The FEBS Journal, vol.119, issue.11, pp.1712-1725, 2017.
DOI : 10.1038/srep31119

J. E. Towne, B. R. Renshaw, J. Douangpanya, B. P. Lipsky, M. Shen et al., Interleukin-36 (IL-36) Ligands Require Processing for Full Agonist (IL-36??, IL-36??, and IL-36??) or Antagonist (IL-36Ra) Activity, Journal of Biological Chemistry, vol.167, issue.49, pp.42594-42602, 2011.
DOI : 10.1056/NEJMoa1013068

URL : http://www.jbc.org/content/286/49/42594.full.pdf

J. S. Ainscough, T. Macleod, D. Mcgonagle, R. Brakefield, J. M. Baron et al., Cathepsin S is the major activator of the psoriasis-associated proinflammatory cytokine IL-36??, Proc. Natl. Acad. Sci, pp.2748-2757, 2017.
DOI : 10.1517/13543784.16.9.1327

T. Aoyagi, M. W. Newstead, X. Zeng, S. L. Kunkel, M. Kaku et al., IL-36 receptor deletion attenuates lung injury and decreases mortality in murine influenza pneumonia, Mucosal Immunology, vol.3, issue.4, pp.1043-1055, 2017.
DOI : 10.2217/nnm.13.149

A. M. Ellisdon, C. A. Nold-petry, L. D-'andrea, S. X. Cho, J. C. Lao et al., Homodimerization attenuates the anti-inflammatory activity of interleukin-37, Science Immunology, vol.8, issue.8, 2017.
DOI : 10.1107/S0907444904026460

M. F. Nold, C. A. Nold-petry, J. A. Zepp, B. E. Palmer, P. Bufler et al., IL-37 is a fundamental inhibitor of innate immunity, Nature Immunology, vol.181, issue.11, pp.1014-1022, 1944.
DOI : 10.4049/jimmunol.181.1.557

C. Garlanda, C. A. Dinarello, and A. Mantovani, The Interleukin-1 Family: Back to the Future, Immunity, vol.39, issue.6, pp.1003-1018, 2013.
DOI : 10.1016/j.immuni.2013.11.010

A. Bulau, M. F. Nold, S. Li, C. A. Nold-petry, M. Fink et al., Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses, Proceedings of the National Academy of Sciences, vol.9, issue.8, pp.2650-2655, 2014.
DOI : 10.1038/ni.1636

X. L. Yuan, Y. Li, X. H. Pan, M. Zhou, Q. Y. Gao et al., Production of recombinant human interleukin-38 and its inhibitory effect on the expression of proinflammatory cytokines in THP-1 cells, Molecular Biology, vol.50, issue.3, pp.466-473, 2016.
DOI : 10.1134/S0026893316030134

G. Lopez-castejon and D. Brough, Understanding the mechanism of IL-1?? secretion, Cytokine & Growth Factor Reviews, vol.22, issue.4, pp.189-195, 2011.
DOI : 10.1016/j.cytogfr.2011.10.001

K. Jiang, Y. Guo, L. Xiao, W. Pan, and J. Ma, Dendritic cells should not be overlooked when studying the effect of IL-38 administration in arthritis, Annals of the Rheumatic Diseases, 2017.
DOI : 10.1136/annrheumdis-2017-211780

M. Boutet, F. Blanchard, B. Le-goff, and . Jiang, Response to: " Does IL-38 act on macrophages and/or dendritic cells in arthritis, Ann. Rheum. Dis, 2017.

C. Gabay and J. E. Towne, Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions, Journal of Leukocyte Biology, vol.90, issue.4, pp.645-6523, 2015.
DOI : 10.1038/labinvest.2009.148

M. Hahn, S. Frey, and A. J. Hueber, The novel interleukin-1 cytokine family members in inflammatory diseases, Current Opinion in Rheumatology, vol.29, issue.2, pp.208-213, 2017.
DOI : 10.1097/BOR.0000000000000361

Y. Shaik, G. Sabatino, G. Maccauro, G. Varvara, G. Murmura et al., IL-36 Receptor Antagonist with Special Emphasis on IL-38, International Journal of Immunopathology and Pharmacology, vol.25, issue.1, pp.27-36, 2013.
DOI : 10.1177/1721727X1201000102

URL : http://journals.sagepub.com/doi/pdf/10.1177/039463201302600103

F. L. Van-de-veerdonk and M. G. Netea, New Insights in the Immunobiology of IL-1 Family Members, Frontiers in Immunology, vol.4, issue.167, 2013.
DOI : 10.3389/fimmu.2013.00167

Z. Hu, Z. Chen, N. Huang, X. Teng, J. Zhang et al., Expression, purification of IL-38 in Escherichia coli and production of polyclonal antibodies, Protein Expression and Purification, vol.107, pp.76-82, 2015.
DOI : 10.1016/j.pep.2014.10.016

L. Tortola, E. Rosenwald, B. Abel, H. Blumberg, M. Schäfer et al., Psoriasiform dermatitis is driven by IL-36???mediated DC-keratinocyte crosstalk, Journal of Clinical Investigation, vol.122, issue.11, pp.3965-3976, 2012.
DOI : 10.1172/JCI63451DS1

URL : http://www.jci.org/articles/view/63451/files/pdf

D. Dietrich, P. Martin, V. Flacher, Y. Sun, D. Jarrossay et al., Interleukin-36 potently stimulates human M2 macrophages, Langerhans cells and keratinocytes to produce pro-inflammatory cytokines, Cytokine, vol.84, pp.88-98, 2016.
DOI : 10.1016/j.cyto.2016.05.012

S. Mutamba, A. Allison, Y. Mahida, P. Barrow, and N. Foster, Expression of IL-1Rrp2 by human myelomonocytic cells is unique to DCs and facilitates DC maturation by IL-1F8 and IL-1F9, European Journal of Immunology, vol.179, issue.3, pp.607-617, 2012.
DOI : 10.1084/jem.179.4.1109

S. Vigne, G. Palmer, C. Lamacchia, P. Martin, D. Talabot-ayer et al., IL-36R ligands are potent regulators of dendritic and T cells, Blood, vol.118, issue.22, pp.5813-5823, 2011.
DOI : 10.1182/blood-2011-05-356873

R. Penha, J. Higgins, S. Mutamba, P. Barrow, Y. Mahida et al., IL-36 receptor is expressed by human blood and intestinal T lymphocytes and is dose???dependently activated via IL-36?? and induces CD4+ lymphocyte proliferation, Cytokine, vol.85, pp.18-25, 2016.
DOI : 10.1016/j.cyto.2016.05.023

URL : http://eprints.nottingham.ac.uk/41582/1/Penha%20et%20al%20Cytokine.pdf

M. S. Gresnigt, B. Rösler, C. W. Jacobs, K. L. Becker, L. A. Joosten et al., induced Th1 and Th17 responses, European Journal of Immunology, vol.163, issue.2, pp.416-426, 2013.
DOI : 10.1002/art.22848

S. Vigne, G. Palmer, P. Martin, C. Lamacchia, D. Strebel et al., IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells, Blood, vol.120, issue.17, pp.3478-3487, 2012.
DOI : 10.1182/blood-2012-06-439026

H. Chi, K. Hua, Y. Lin, C. Chu, C. Hsieh et al., IL-36 Signaling Facilitates Activation of the NLRP3 Inflammasome and IL-23/IL-17 Axis in Renal Inflammation and Fibrosis, Journal of the American Society of Nephrology, vol.28, issue.7, pp.2022-2037, 2017.
DOI : 10.1681/ASN.2016080840

C. Lamacchia, G. Palmer, E. Rodriguez, P. Martin, S. Vigne et al., The severity of experimental arthritis is independent of IL-36 receptor signaling, Arthritis Research & Therapy, vol.15, issue.2, 2013.
DOI : 10.1002/eji.200526167

A. Derer, B. Groetsch, U. Harre, C. Böhm, J. Towne et al., Blockade of IL-36 Receptor Signaling Does Not Prevent from TNF-Induced Arthritis, PLoS ONE, vol.15, issue.8, 2014.
DOI : 10.1371/journal.pone.0101954.g005

D. Boraschi and A. Tagliabue, The interleukin-1 receptor family, Seminars in Immunology, vol.25, issue.6, pp.394-407, 2013.
DOI : 10.1016/j.smim.2013.10.023

T. L. Born, D. E. Smith, K. E. Garka, B. R. Renshaw, J. S. Bertles et al., Identification and characterization of two members of a novel class of the inter- leukin-1 receptor (IL-1R) family. Delineation Of a new class of IL-1R-related proteins based on signaling, J. Biol. Chem, pp.275-29946, 2000.

A. Piton, J. L. Michaud, H. Peng, S. Aradhya, J. Gauthier et al., Mutations in the calcium-related gene IL1RAPL1 are associated with autism, Human Molecular Genetics, vol.132, issue.5, pp.3965-3974, 2008.
DOI : 10.1523/JNEUROSCI.4554-04.2005

M. Nawara, J. Klapecki, K. Borg, M. Jurek, S. Moreno et al., Novel mutation of IL1RAPL1 gene in a nonspecific X-linked mental retardation (MRX) family, Am. J. Med. Genet. A, vol.146, pp.3167-3172, 2008.

L. Laino, I. Bottillo, C. Piedimonte, L. Bernardini, B. Torres et al., Clinical and molecular characterization of a boy with intellectual disability, facial dysmorphism, minor digital anomalies and a complex IL1RAPL1 intragenic rearrangement, European Journal of Paediatric Neurology, vol.20, issue.6, pp.971-976, 2016.
DOI : 10.1016/j.ejpn.2016.07.003

M. Ramos-brossier, C. Montani, N. Lebrun, L. Gritti, C. Martin et al., Novel IL1RAPL1 mutations associated with intellectual disability impair synaptogenesis, Human Molecular Genetics, vol.6, issue.4, pp.1106-1118, 2015.
DOI : 10.1021/pr0701308

URL : https://hal.archives-ouvertes.fr/inserm-01102927

T. Yoshida, M. Yasumura, T. Uemura, S. Lee, M. Ra et al., IL-1 Receptor Accessory Protein-Like 1 Associated with Mental Retardation and Autism Mediates Synapse Formation by Trans-Synaptic Interaction with Protein Tyrosine Phosphatase ??, Journal of Neuroscience, vol.31, issue.38, pp.13485-13499, 2011.
DOI : 10.1523/JNEUROSCI.2136-11.2011

M. Yasumura, T. Yoshida, M. Yamazaki, M. Abe, R. Natsume et al., IL1RAPL1 knockout mice show spine density decrease, learning deficiency, hyperactivity and reduced anxiety-like behaviours, Scientific Reports, vol.85, issue.1, 2015.
DOI : 10.3791/50871

URL : http://www.nature.com/articles/srep06613.pdf

A. Pavlowsky, A. Zanchi, M. Pallotto, M. Giustetto, J. Chelly et al., Neuronal JNK pathway activation by IL-1 is mediated through IL1RAPL1, a protein required for development of cognitive functions, Communicative & Integrative Biology, vol.23, issue.3, pp.245-247, 2010.
DOI : 10.1523/JNEUROSCI.5352-08.2009

F. Gambino, A. Pavlowsky, A. Begle, J. Dupont, N. Bahi et al., IL1-receptor accessory protein-like 1 (IL1RAPL1), a protein involved in cognitive functions, regulates N-type Ca2+-channel and neurite elongation, Proc. Natl. Acad
DOI : 10.1083/jcb.200203027

J. A. Khan, E. K. Brint, L. A. O-'neill, and L. Tong, Crystal Structure of the Toll/Interleukin-1 Receptor Domain of Human IL-1RAPL, Journal of Biological Chemistry, vol.5, issue.30, pp.31664-31670, 2004.
DOI : 10.1016/0263-7855(87)80010-3

T. Hayashi, T. Yoshida, M. Ra, R. Taguchi, and M. Mishina, IL1RAPL1 Associated with Mental Retardation and Autism Regulates the Formation and Stabilization of Glutamatergic Synapses of Cortical Neurons through RhoA Signaling Pathway, PLoS ONE, vol.141, issue.6, 2013.
DOI : 10.1371/journal.pone.0066254.s002

C. R. Marques, G. N. Costa, T. M. Da-silva, P. Oliveira, A. A. Cruz et al., Suggestive association between variants in IL1RAPL and asthma symptoms in Latin American children, European Journal of Human Genetics, vol.38, issue.4, pp.25-439, 2017.
DOI : 10.1002/ajmg.a.30123

M. Molgora, I. Barajon, A. Mantovani, and C. Garlanda, Regulatory role of IL-1R8 in immunity and disease, Front, Immunol, vol.7, 2016.

C. Costelloe, M. Watson, A. Murphy, K. Mcquillan, C. Loscher et al., IL-1F5 mediates anti-inflammatory activity in the brain through induction of IL-4 following interaction with SIGIRR/TIR8, Journal of Neurochemistry, vol.14, issue.5, pp.1960-1969, 2008.
DOI : 10.1038/ni968

M. Zhao, Y. Hu, J. Jin, Y. Yu, S. Zhang et al., Interleukin 37 promotes angiogenesis through TGF-? signaling, Sci, 2017.
DOI : 10.1038/s41598-017-06124-z

URL : https://doi.org/10.1038/s41598-017-06124-z

M. Keermann, S. Kõks, E. Reimann, K. Abram, T. Erm et al., Expression of IL-36 family cytokines and IL-37 but not IL-38 is altered in psoriatic skin, Journal of Dermatological Science, vol.80, issue.2, pp.150-152, 2015.
DOI : 10.1016/j.jdermsci.2015.08.002

J. N. Fullerton and D. W. Gilroy, Resolution of inflammation: a new therapeutic frontier, Nature Reviews Drug Discovery, vol.182, issue.8, pp.551-567, 2016.
DOI : 10.4049/jimmunol.0801739

M. H. Hong, H. Williams, C. H. Jin, and J. W. Pike, The Inhibitory Effect of Interleukin-10 on Mouse Osteoclast Formation Involves Novel Tyrosine-Phosphorylated Proteins, Journal of Bone and Mineral Research, vol.137, issue.5, pp.911-918, 2000.
DOI : 10.1128/MCB.19.5.3485

Y. Song and J. M. Yang, Role of interleukin (IL)-17 and T-helper (Th)17??cells in cancer, Biochemical and Biophysical Research Communications, vol.493, issue.1, pp.493-2017
DOI : 10.1016/j.bbrc.2017.08.109

E. Robak, L. Kulczycka-siennicka, Z. Gerlicz, M. Kierstan, A. Korycka-wolowiec et al., Sysa-Jedrzejowska, Correlations between concentrations of interleukin (IL)-17A, IL-17 B and IL-17F, and endothelial cells and proangiogenic cytokines in systemic lupus erythematosus patients, Eur, Cytokine Netw, vol.24, pp.60-68, 2013.

T. P. Singh, M. P. Schön, K. Wallbrecht, A. Gruber-wackernagel, X. Wang et al., Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis, T. Garraud et al. Cytokine and Growth Factor Reviews xxx (xxxx) xxx?xxx, PLoS One, vol.8, 2013.

A. Coxon, B. Bolon, J. Estrada, S. Kaufman, S. Scully et al., Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis, Arthritis & Rheumatism, vol.75, issue.10, pp.2604-2612, 2002.
DOI : 10.1210/endo.136.7.7789332

R. Celis, N. Planell, J. L. Fernández-sueiro, R. Sanmartí, J. Ramírez et al., Synovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical features, Arthritis Research & Therapy, vol.14, issue.2, 2012.
DOI : 10.1002/art.10556

L. G. Van-baarsen, M. C. Lebre, D. Van-der-coelen, S. Aarrass, M. W. Tang et al., Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?, Arthritis Research & Therapy, vol.64, issue.4, 2014.
DOI : 10.1002/art.33396

P. Miossec, Update on interleukin-17: a role in the pathogenesis of inflammatory arthritis and implication for clinical practice, RMD Open, vol.3, issue.1, 2017.
DOI : 10.1136/rmdopen-2016-000284

Y. Carrier, H. Ma, H. E. Ramon, L. Napierata, C. Small et al., Inter-Regulation of Th17 Cytokines and the IL-36 Cytokines In Vitro and In Vivo: Implications in Psoriasis Pathogenesis, Journal of Investigative Dermatology, vol.131, issue.12, pp.2428-2437, 2011.
DOI : 10.1038/jid.2011.234

S. Kotake, T. Yago, T. Kobashigawa, and Y. Nanke, The Plasticity of Th17 Cells in the Pathogenesis of Rheumatoid Arthritis, Journal of Clinical Medicine, vol.8, issue.7, 2017.
DOI : 10.1136/annrheumdis-2016-209831

G. Jones, P. Nash, and S. Hall, Advances in rheumatoid arthritis, The Medical Journal of Australia, vol.206, issue.5, pp.221-224, 2017.
DOI : 10.5694/mja16.01287

I. B. Mcinnes, C. D. Buckley, and J. D. Isaacs, Cytokines in rheumatoid arthritis ??? shaping the immunological landscape, Nature Reviews Rheumatology, vol.19, issue.1, pp.63-68, 2015.
DOI : 10.1038/nm.3260

I. B. Mcinnes and G. Schett, Pathogenetic insights from the treatment of rheumatoid arthritis, The Lancet, vol.389, issue.10086, pp.2328-2337, 2017.
DOI : 10.1016/S0140-6736(17)31472-1

L. Rossi-semerano, M. Piram, C. Chiaverini, D. De-ricaud, A. Smahi et al., First Clinical Description of an Infant With Interleukin-36-Receptor Antagonist Deficiency Successfully Treated With Anakinra, PEDIATRICS, vol.132, issue.4, pp.1043-10472012, 2013.
DOI : 10.1542/peds.2012-3935

D. Ummarino, Experimental arthritis: IL-38 promotes anti-inflammatory effects, Nature Reviews Rheumatology, vol.13, issue.5, 2017.
DOI : 10.1038/nrrheum.2017.55